Dengue Vaccine Market Size, Demand & Opportunity Analysis By Type (government, private hospitals, clinics)

Research Nester has recently announced new market demand assessment research titled “Dengue Vaccine Market – Global Demand Analysis & Opportunity Outlook 2021. The global market study provides a granular data and in-depth analysis on the current and future market situations that are crucial for the existing &new players in the market. The industry research is based on key factors like demand & supply analysis, commercial activities, research investments, pricing analysis, government initiatives & guidelines, driving forces in the market, roadblocks and segmentation based on the product viability.

It has been noticed that after the introduction of first dengue vaccine in 2015, the global dengue vaccine market is expected to experience rapid growth throughout the forecast period till 2021. In 2015, the global dengue vaccine market was value at USD 70 million across the five major geographical regions viz. North America, South America, Europe, Africa and Asia-Pacific.

By 2020, the dengue vaccine market is expected to grow substantially in order to reach USD 399 million, expanding at a CAGR of 42% during 2015-2020; Brazil, Singapore, Thailand, India, and Mexico to post highest growth during the forecast period. Dengue is a deadly disease and growing rapidly over the globe, thus, the public health care burden of the affected countries is expected to force government in such countries for widespread immunization as a preventative measure.

In 2015, the global dengue vaccine sales stood at USD 70 million. The global dengue vaccine market is mainly dominated by South America with a revenue of USD 97.6 million and 25% of the market share followed by North America with revenue of USD 217 million and 54.9% revenue share in the same year.  However, the sales growth in North America and Asia are likely to be show dependency on the arrival of less expensive, publically-supplied generic vaccines. Furthermore, the dengue vaccines market in Asia is expected to reach revenue of USD 75.5 million with a market share of 19.5% till 2020.

Demand Analysis By Institutions

  • By Government Institutions
  • By Private Institutions

Key Players

Following are the leading players providing dengue vaccines all across the globe:-

  • Sanofi Pasteur
  • Takeda Pharmaceutical company Ltd
  • Glaxosmithkline Plc
  • Merck & Co Pharmaceutical company Ltd
  • DENVax
  • U.S NIH
  • Instituto Butantan(Brezil)
  • Vabiotec (Vietnam)

Regions Studied:

  • North America (United States / U.S., Canada)
  • Latin America (Mexico, Brazil, Rest of Latin America)
  • Western and Eastern Europe (Germany, Italy, Spain, France, U.K, Benelux, Hungary, Rest Of Western Europe, Russia, Poland, Rest of Eastern Europe)
  • Asia-Pacific (China, India, Singapore, Japan, Australia & New Zealand & Rest of Asia)
  • Rest of World

To know more on coverage, click on the link below:-

http://www.researchnester.com/reports/global-dengue-vaccine-market-analysis-opportunity-outlook-2021/123

Contact Us:
Ajay Daniel
Email: ajay.daniel@researchnester.com
Phone : U.S. +1 646 586 9123
U.K. +44 203 608 5919

Leave a Reply

Your email address will not be published. Required fields are marked *